The new UK coronavirus strain may be 30 to 40 percent more deadly than the original SARS-CoV-2 variant, according to a UK governmental health advisory group, despite initial hopes that the faster-spreading variant of the coronavirus had no greater impact on hospitalizations or death than its predecessor. This new developmentread more

Three  SARS-CoV-2 vaccines have now been fast tracked for development by the FDA. The Oxford group, CanSino Biologics and now also Moderna Pharmaceuticals have all had their experimental vaccines  approved to move into Phase II trials. This means that they will begin enrolling subject participants in the coming weeks. Thisread more